C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2004
12/29/2004	EP1490056A1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
12/29/2004	EP1490055A1 Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
12/29/2004	EP1490054A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer
12/29/2004	EP1490053A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
12/29/2004	EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators
12/29/2004	EP1263723A4 Ningalin b analogs employable for reversing multidrug resistance
12/29/2004	EP1206442A4 Substituted chiral allosteric hemoglobin modifiers
12/29/2004	EP1176140B1 Amide compounds and medicinal use thereof
12/29/2004	EP1163209A4 Compounds and compositions for delivering active agents
12/29/2004	EP1032560B1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate
12/29/2004	CN1558898A Antiviral agent
12/29/2004	CN1558897A Antidiabetic agents
12/29/2004	CN1558758A Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
12/29/2004	CN1557945A Preparation of lactams from aliphatic alpha , omega -dinitiles
12/29/2004	CN1182116C Mutilin derivatives and their use as antibacterials
12/29/2004	CN1182113C 2,5-cis-bisubstituted pyrrolidine derivative, its synthesizing method and usage
12/29/2004	CN1181817C NF-KB inhibitors containing phenylmethyl benzoquinone as active ingredient
12/29/2004	CA2534094A1 Glycosidase inhibitors and methods of synthesizing same
12/29/2004	CA2529257A1 Methods and compositions for treating amyloid-related diseases
12/29/2004	CA2529256A1 Methods and compositions for treating amyloid-related diseases
12/28/2004	US6835727 Bone disorders; osteoporosis; rheumatic diseases
12/28/2004	US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
12/23/2004	WO2004111193A2 Prodrugs of mitotic kinesin inhibitors
12/23/2004	WO2004111003A1 Amide derivatives as selective serotonin re-uptake inhibitors
12/23/2004	WO2004110997A1 3- sulfonylamino- pyrrolidine- 2- one derivatives as inhibitors of factor xa
12/23/2004	WO2004110996A1 Nk1 antagonist
12/23/2004	WO2004110995A1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
12/23/2004	WO2004110994A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams
12/23/2004	WO2004110432A1 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases
12/23/2004	WO2004110364A2 Thiotungstate analogues and uses thereof
12/23/2004	WO2004072025A3 Substituted n-arylheterocycles, method for production and use thereof as medicaments
12/23/2004	WO2004064771A3 Geminally di-substituted nsaid derivatives as abeta 42 lowering agents
12/23/2004	US20040260038 Produced by reacting a thiol and a maleic acid compound, especially thio derivatives with succinic anhydride, succinate or bissuccinimide groups; useful as thermally dissociatable curing agents, particularly for epoxy resins and polyurethanes
12/23/2004	US20040260033 Living and quasiliving cationic telechelic polymers quenched by N-substituted pyrrole and methods for their preparation
12/23/2004	US20040260027 Process for forming polyalkenyl acylating agents
12/23/2004	US20040259933 Process for producing levetiracetam
12/23/2004	US20040259931 An urea derivative containing amide, amine or substitued amine groups and pyrrolidine ring(s), useful for treating obesity, anxiety or depression
12/23/2004	US20040259921 EP4 receptor selective agonists in the treatment of osteoporosis
12/23/2004	US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence
12/23/2004	US20040259908 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid
12/23/2004	US20040259877 Inhibitors against the production and release of inflammatory cytokines
12/23/2004	US20040259868 Serine protease inhibitors
12/23/2004	US20040259860 Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
12/23/2004	US20040259843 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents
12/23/2004	US20040259808 Captopril derivatives
12/23/2004	US20040258620 In vivo stability, biocompatibility, organ specificity; low dosage, rapid excretion; nuclear magnetic resonance diagnostic imaging, radiotherapy
12/23/2004	CA2529478A1 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases
12/23/2004	CA2528652A1 Nk1 antagonist
12/23/2004	CA2528644A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams
12/23/2004	CA2527582A1 Prodrugs of mitotic kinesin inhibitors
12/23/2004	CA2527236A1 Thiotungstate analogues and uses thereof
12/23/2004	CA2523808A1 Pyrrole compounds and uses thereof
12/22/2004	EP1489109A2 Living and quasiliving cationic telechelic polymers quenched by N-substituted pyrrole and methods for their preparation
12/22/2004	EP1489107A2 Process for forming polyalkenylacylating agents, lubricating oil and additive for a lubricating oil
12/22/2004	EP1489106A1 Arene-ruthenium complexes immobilized on polymers, catalysts consisting of the complexes, and processes for organic syntheses with the same
12/22/2004	EP1488418A1 Squarylium dyes as a light-absorbing compound in the information layer of optical data carriers
12/22/2004	EP1487843A2 Substituted phenylacetic acids
12/22/2004	EP1487807A2 New compounds
12/22/2004	EP1487796A1 Substituted biaryl amides as c5a receptor modulators
12/22/2004	EP1487791A1 A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)- methylethyl pentanoate
12/22/2004	EP1487790A1 Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization
12/22/2004	EP1487437A1 Methods of treatment with selective ep4 receptor agonists
12/22/2004	CN1556788A Muscarinic agonists
12/22/2004	CN1181054C Process for preparing D-proline
12/22/2004	CN1181053C Process for preparing 3-(7-amidino-2-naphthyl) 2-phenylpropionic acid derivs.
12/22/2004	CN1181043C Quaternary bis-ammonium salt precursors and their uses as prodrugs having antiparasitic activity
12/21/2004	CA2241904C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
12/19/2004	CA2801104A1 Living and quasiliving cationic telechelic polymers quenched by n-substituted pyrrole and methods for their preparation
12/16/2004	WO2004108685A1 Aryl-heteroaromatic products, compositions containing same and use thereof
12/16/2004	WO2004108670A1 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure
12/16/2004	WO2004108669A1 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
12/16/2004	WO2004108636A2 Isotopically labeled chemically stable reagents and process for the synthesis thereof
12/16/2004	WO2004108634A2 Reagents for modifying biopharmaceuticals, the use and production thereof
12/16/2004	WO2004108070A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers
12/16/2004	WO2004080411A3 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
12/16/2004	WO2004050022A8 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/16/2004	US20040254376 Cyclic amidine derivative
12/16/2004	US20040254344 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/16/2004	US20040254226 Antiinflamamtory agents; autoimmune disease; immunosuppressants;multiple sclerosis; antiarthritic agents
12/16/2004	US20040254219 Muscarinic receptors; chronic obstructive pulmonary disease; asthma
12/16/2004	US20040254156 opioid receptor agonists such as 2-[4-(methanesulfonylamino-methyl)-phenyl]-N-methyl-N-[1-(S)-phenyl-2-pyrrolidin-1-ylethyl]-acetamide used for preventing pain, pruritus and gastrointestinal disorders
12/16/2004	US20040254093 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antidiabetic agents
12/16/2004	CA2528093A1 Aryl-heteroaromatic products, compositions containing same and use thereof
12/16/2004	CA2528006A1 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
12/16/2004	CA2526007A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers
12/15/2004	EP1486487A1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate
12/15/2004	EP1486486A2 Substituted B-thiocarboxylic acids
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485351A2 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams
12/15/2004	EP1485348A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485347A2 Hif hydroxylase inhibitors
12/15/2004	EP1485343A1 Amorphous hmg-coa reductase inhibitors of desired particle size
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1263711B1 Novel use of phenylheteroalkylamine derivatives
12/15/2004	EP1109816A4 Vinyl substituted cyclic products of the ene-yne reaction

1 ... 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 ... 404